REFERENCES
- ATS Board of Directors: Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987–2001.
- Baumann MH, Strange C, Heffner JE, Light R, Kirby TJ, Klein J, Luketich JD, Panacek EA, Sahn SA: Management of spontaneous pneumothorax : an American college of chest physicians delphi consensus statement. Chest. 2001;119(2):590–602.
- Antunes G, Neville E, Duffy J, Ali N: BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58 (Suppl 2):ii29–ii38.
- Henry M, Arnold T, Harvey J: BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003;58(90002):ii39–ii52.
- Tremblay A, Michaud G: Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362–368.
- Putnam JB, Jr., Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86(10):1992–1999.
- Tremblay A, Stather DR, Kelly MM: Effect of repeated administration of low-dose silver nitrate for pleurodesis in a rabbit model. Respirology. 2011;16(7):1070–1075.
- Lee YC, Malkerneker D, Devin CJ, Thompson PJ, Johnson JE, Lane KB, Light RW: Comparing transforming growth factor beta-2 and fibronectin as pleurodesing agents. Respirology. 2001;6(4):281–286.
- Lee YC, Lane KB, Parker RE, Ayo DS, Rogers JT, Diters RW, Thompson PJ, Light RW: Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. Thorax. 2000;55(12):1058–1062.
- Gary Lee YC, Teixeira LR, Devin CJ, Vaz MA, Vargas FS, Thompson PJ, Lane KB, Light RW: Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 2001;163(3 Pt 1):640–644.
- Lee YC, Yasay JR, Johnson JE, Parker RE, Thompson PJ, Lane KB, Light RW: Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology. 2002;7(3):209–216.
- Vargas FS, Teixeira LR, Silva LM, Carmo AO, Light RW: Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. Chest 1995;108(4):1080–1083.
- Vargas FS, Teixeira LR, Vaz MA, Carmo AO, Marchi E, Cury PM, Light RW: Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. Chest 2000;118(3):808–813.
- Tremblay A, Stather D, Kelly M: Effect of repeated administration of low-dose silver nitrate for pleurodesis in a rabbit model. Respirology. 2011;16(7):1070–1075.
- Lorch DG, Gordon L, Wooten S, Cooper JF, Strange C, Sahn SA: Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest. 1988;93(3):527–529.
- Teixeira LR, Vargas FS, Antonangelo L, Mattos VC, Vaz MA, Acencio MM, Marchi E: Low concentration silver nitrate pleurodesis in rabbits: optimal concentration for rapid and complete sclerosing effect. Lung. 2003;181(6):353–359.
- Warren WH, Kalimi R, Khodadadian LM, Kim AW: Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg. 2008;85(3):1049–1055.